期刊文献+

拉贝洛尔与硝酸甘油治疗高血压急症212例临床对比研究 被引量:3

Clinical analysis of 212 cases of labetalol and nitroglycerin treatment of hypertensive emergency
下载PDF
导出
摘要 目的了解拉贝洛尔与硝酸甘油治疗高血压急症的临床疗效及不良反应。方法回顾性分析2010年1月~2013年6月急诊抢救室收治的212例使用拉贝洛尔与硝酸甘油治疗高血压急症患者的临床资料,观察拉贝洛尔及硝酸甘油在治疗以后不同时间点的血压变化以及不良反应,评估拉贝地尔的疗效和安全性。结果拉贝洛尔与硝酸甘油在降血压方面无明显统计学差异,但不良反应方面拉贝洛尔较硝酸甘油少,有统计学差异。结论拉贝洛尔治疗高血压急症的降压效果好,降压平稳,副作用发生少,临床上更易优先选用。 Objective To investigate the clinical efficacy and side effect of labetalol and nitroglycerin treatment of hypertensive emergencies. Methods A retrospective analysis was performed on 212 cases of labetalol and nitroglycerin treatment of hypertensive in emergency room in between January 2010 and June 2013. Observation was made on their blood pressure changes of labetalol and nitroglycerin in treatment at different time points and adverse reaction, as well as the evaluation on efficacy and safety of Labeidier. Results No statistical difference was found in treating high blood pressure but with less adverse effects of labetalol than nitroglycerin, with a significant difference. Conclusion Labetalol is considered being effective in treating hypertensive with less side effect, and recommended for clinical use.
出处 《中国急救复苏与灾害医学杂志》 2014年第12期1117-1119,共3页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 拉贝洛尔 硝酸甘油 高血压急症 Labetalol Nitroglycerin Hypertensive emergency
  • 相关文献

参考文献8

二级参考文献39

  • 1秋楠,缪星宇,魏建文,许彦钢,王继军,杨军.盐酸乌拉地尔治疗出血性脑卒中围手术期高血压的疗效观察[J].中国药房,2005,16(14):1096-1097. 被引量:5
  • 2武怡.乌拉地尔与硝酸甘油治疗高血压急症的临床观察[J].西部医学,2006,18(2):161-162. 被引量:3
  • 3傅国根.硝酸甘油与硝普钠治疗高血压急症的疗效观察[J].高血压杂志,2006,14(3):226-227. 被引量:41
  • 4陈海波,杨俊芬.经微量泵静脉注射硝普钠治疗高血压急症的疗效观察[J].心血管康复医学杂志,2007,16(3):264-266. 被引量:2
  • 5Manrique C,Giles TD,Ferdinand KC,et al.Realities of newer beta-blockers for the management of hypertension[J].J Clin Hypertens (Greenwich),2009,11(7):369-375.
  • 6Wehling M.Multimorbidity and polypharmacy:which betablocker to use in relation to the pharmacokinetic profile and interaction potential[J].Arzneimittelforschung,2010,60(2):57-63.
  • 7Weber MA,Sica DA,Tarka EA,et al.Controlled-release carvedilol in the treatment of essential hypertension[J].Am J Cardiol,2006,98(7A):32L-38L.
  • 8Weber MA,Bakris GL,Tarka EA,et al.Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension[J].J Clin Hypertens (Greenwich),2006,8(12):840-849.
  • 9Fonarow GC,Deedwania P,Fonseca V,et al.Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension:results of the extended-release carvedilol lipid trial[J].J Am Soc Hypertens,2009,3(3):210-220.
  • 10Bakris GL,Bell DS,Fonseca V,et al.The rationale and design of the glycemic effects in diabetes mellitus carvedilol-metoprolol comparison in hypertensives (GEMINI) trial[J].J Diabetes Complications,2005,19(2):74-79.

共引文献138

同被引文献23

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部